Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Immunotech Biopharm Ltd ( (HK:6978) ) just unveiled an announcement.
Immunotech Biopharm Ltd has announced a discloseable transaction involving the subscription of structured deposit products from Bank of China Limited, with a total investment value of RMB120,000,000. This strategic financial move is subject to the notification and announcement requirements under the Listing Rules, highlighting the company’s efforts to manage its financial assets effectively and potentially enhance its financial returns through structured investments.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, focusing on the biotechnology sector. The company is involved in developing and providing biopharmaceutical products, with a market focus on innovative healthcare solutions.
Average Trading Volume: 1,252,525
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.94B
Find detailed analytics on 6978 stock on TipRanks’ Stock Analysis page.